Semaglutide’s patent expired on Friday, and several top Indian drugmakers will launch cheaper generics immediately, with intense competition expected.
Emcure betting on innovator edge in crowded weight-loss drug market
Related Posts
Lightbox, the investor behind Rebel Foods, has returned one-third of its second fund to its investors.
Rebel Foods Secures $210 Million Investment Led by Temasek Rebel Foods, known for its brands like Faasos, Oven Story, and…
According to a source, India’s market regulator plans to expand its investigation into Jane Street.
By Jayshree P Upadhyay MUMBAI (Reuters) -India’s markets regulator has widened an investigation into alleged market manipulation by U.S. securities…
Sumitomo Mitsui’s earnings surpass forecasts as interest rate increases take effect.
Sumitomo Mitsui Financial Group Inc. reported a profit that exceeded analysts’ expectations in the fiscal third quarter, positioning the company…
